Integrating buprenorphine prescribing into OTP
Poster of same model.
Integrating buprenorphine prescribing into OTP
Poster of same model.
These findings suggest that take-home naloxone supplied to patients in opioid treatment programs may be part of a targeted harm-reduction strategy to reduce negative outcomes associated with opioid overdose in the community.
An opioid treatment program (OTP) and a federally qualified health center (FQHC) partnered to develop and implement an innovative integrated methadone and primary care treatment model. The process for integrating an OTP and FQHC to provide methadone treatment in the primary care setting will be discussed.
The objective of this narrative review is to describe strategies for the integration of evidence-based harm reduction principles and interventions into outpatient, primary care–based OUD treatment settings.
A 1996 guidance document produced by Edith Springer, a pioneer of U.S. Harm Reduction